| [1] Luo CQ, Fang Y, Tu CQ, et al. Current treatment situation and progress on bone defect of collapsed tibial plateau fractures. Zhongguo Gu Shang. 2016;29(2):187-191.[2] Tall M. Treatment of aseptic tibial shaft non-union without bone defect. Orthop Traumatol Surg Res. 2018;104(1S): S63-S69. [3] Brinker MR, O'Connor DP. Management of Aseptic Tibial and Femoral Diaphyseal Nonunions Without Bony Defects. Orthop Clin North Am. 2016;47(1):67-75.[4] Tang D, Tare RS, Yang LY, et al. Biofabrication of bone tissue: approaches, challenges and translation for bone regeneration. Biomaterials. 2016;83:363-382.[5] Black CR, Goriainov V, Gibbs D, et al. Bone Tissue Engineering. Curr Mol Biol Rep. 2015;1(3):132-140.[6] 单连成,王刚,张长青,等.富血小板血浆对体外培养骨骼肌干细胞增殖及成骨活性的作用[J].中国组织工程研究与临床康复, 2009, 13(20):3833-3837.[7] Qu Z, Balkir L, van Deutekom JC, et al. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol. 1998;142(5): 1257-1267. [8] 单连成,王刚,张长青,等.不同浓度PRP对骨骼肌干细胞成骨分化的影响[J],中国修复重建外科杂志,2009,23(8):991-996.[9] Lane JM, Sandhu HS. Current approaches to experimental bone grafting. Orthop Clin North Am. 1987;18(2):213-225.[10] Pobloth AM, Schell H, Petersen A, et al. Tubular open-porous β-tricalcium phosphate polycaprolactone scaffolds as guiding structure for segmental bone defect regeneration in a novel sheep model. J Tissue Eng Regen Med. 2018;12(4):897-911.[11] Decambron A, Manassero M, Bensidhoum M, et al. A comparative study of tissue-engineered constructs from Acropora and Porites coral in a large animal bone defect model. Bone Joint Res. 2017;6(4):208-215.[12] Parizi AM, Oryan A, Shafiei-Sarvestani Z, et al. Effectiveness of synthetic hydroxyapatite versus Persian Gulf coral in an animal model of long bone defect reconstruction. J Orthop Traumatol. 2013;14(4):259-268.[13] Martinez SA, Probst CW, Hauptman JG, et al. Effects of a fixed compression load on the osteogenic effect of autogenous cancellous bone grafts in dogs. Am J Vet Res. 1992;53(12):2381-2385.[14] Turner TM, Urban RM, Hall DJ, et al. Restoration of large bone defects using a hard-setting, injectable putty containing demineralized bone particles compared to cancellous autograft bone. Orthopedics. 2003;26(5 Suppl):s561-565.[15] Nuss KM, Auer JA, Boos A, et al. An animal model in sheep for biocompatibility testing of biomaterials in cancellous bones. BMC Musculoskelet Disord. 2006;7:67.[16] Pobloth AM, Johnson KA, Schell H, et al. Establishment of a preclinical ovine screening model for the investigation of bone tissue engineering strategies in cancellous and cortical bone defects. BMC Musculoskelet Disord. 2016;17:111.[17] Prat S, Gallardo-Villares S, Vives M, et al. Clinical translation of a mesenchymal stromal cell-based therapy developed in a large animal model and two case studies of the treatment of atrophic pseudoarthrosis. J Tissue Eng Regen Med. 2018; 12(1): e532-e540.[18] Qian W, Gong L, Cui X, et al. Nanotopographic Regulation of Human Mesenchymal Stem Cell Osteogenesis. ACS Appl Mater Interfaces. 2017;9(48):41794-41806.[19] Fan X, Li L, Ye Z, et al. Regulation of osteogenesis of human amniotic mesenchymal stem cells by sodium butyrate. Cell Biol Int. 2018;42(4):457-469.[20] Bilem I, Plawinski L, Chevallier P, et al. The spatial patterning of RGD and BMP-2 mimetic peptides at the subcellular scale modulates human mesenchymal stem cells osteogenesis. J Biomed Mater Res A. 2018;106(4):959-970.[21] Heo JS, Lee SG, Kim HO. Distal-less homeobox 5 is a master regulator of the osteogenesis of human mesenchymal stem cells. Int J Mol Med. 2017;40(5):1486-1494.[22] Tohidnezhad M, Varoga D, Wruck CJ, et al. Platelets display potent antimicrobial activity and release human beta-defensin 2. Platelets. 2012;23(3):217-223.[23] Khojasteh A, Behnia H, Dashti SG, et al. Current trends in mesenchymal stem cell application in bone augmentation: a review of the literature. J Oral Maxillofac Surg. 2012;70(4): 972-982.[24] Li S, Huang KJ, Wu JC, et al. Peripheral blood-derived mesenchymal stem cells: candidate cells responsible for healing critical-sized calvarial bone defects. Stem Cells Transl Med. 2015;4(4):359-368.[25] New SE, Alvarez-Gonzalez C, Vagaska B, et al. A matter of identity - Phenotype and differentiation potential of human somatic stem cells. Stem Cell Res. 2015;15(1):1-13.[26] Morcos MW, Al-Jallad H, Hamdy R. Comprehensive Review of Adipose Stem Cells and Their Implication in Distraction Osteogenesis and Bone Regeneration. Biomed Res Int. 2015; 2015:842975.[27] Arrighi N, Moratal C, Clément N, et al. Characterization of adipocytes derived from fibro/adipogenic progenitors resident in human skeletal muscle. Cell Death Dis. 2015;6:e1733.[28] Liu R, Birke O, Morse A, et al. Myogenic progenitors contribute to open but not closed fracture repair. BMC Musculoskelet Disord. 2011;12:288.[29] Cairns DM, Liu R, Sen M, et al. Interplay of Nkx3.2, Sox9 and Pax3 regulates chondrogenic differentiation of muscle progenitor cells. PLoS One. 2012;7(7):e39642.[30] Mifune Y, Matsumoto T, Takayama K, et al. The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Osteoarthritis Cartilage. 2013;21(1):175-185.[31] Samuel S, Ahmad RE, Ramasamy TS, et al. Platelet rich concentrate enhances mesenchymal stem cells capacity to repair focal cartilage injury in rabbits. Injury. 2018;49(4): 775-783. |
.jpg)
.jpg)
.jpg)
.jpg)